CTN :43391397
19 Jan, 2026
NA
Tender For corrigendum : phsc/proc./rc/mededl/2025/49 - medicines under edl (exclusive gst) gst will be charged as applicable, benzathene pencilin 12lac units-vial inj, bupivacaine 0.5% plain (bupivacaine hcl, ip) inj, anhydrous bupivacaine hydrochloride ip 5mg, dextrose i.p (mohohydrate) 80mg, water for injection q.s., 4 ml amp., carboprost tromethamine 250mcg/ml inj, carboxy methyl cellulose eye drops 10ml vial, chlorpromazine hcl 25mg/ml) inj, haloperidol 5mg /ml inj, i.v. fluid (n/2+destrose 5%), iron and folic acid large (red) : each enteric coated tablet containing ferrous sulphate ip equivalent to elemental iron 60 mg and folic acid 0.5 mg, isoxsuprine hcl 5mg/ml inj, lorazepam 2 mg/ml. inj ip, multian cl
ass="text-red-selected">vit
aminan> t
ab/c
ap thi
amine mononitr
ate ip : 2mg, ribofl
avin ip : 2mg, pyridoxine hcl ip : 0.5mg, pyridoxine hcl ip : 0.5mg, ni
acin
amide ip: 25mg, c
alcium p
antothen
ate ip : 1 mg,
ascorbic
acid 50 mg, folic
acid 0.2 mg, nifedipine 10 mg, ip t
ab, nitroglycerine 5mg/ml inj, pl
asm
a volume exp
ander 3.5% polygeline infusion 500 ml, pr
alidoxime chloride ip 500 mg inj, prometh
azine hcl 25 mg/ml inj, solution povidone iodine 10% w/v, lignoc
aine inj. 4% ip, drot
averine 40 mg/2 ml inj., hcg 2000 iu inj., hcg 5000 iu inj., levo s
albut
amol respir
ator 0.31 mg /2.5 ml, medroxyprogestrone 10 mg c
ap/t
ab., mephentermine 15 mg/ 1 ml inj. ip, micronised progesterone 200 mg inj., misoprost 25 mcg t
ab., v
aleth
am
ate bromide 8 mg/ 1 ml inj., v
ancomycin 250 mg inj.,
an class="text-red-selected">vitaminan> k 1 mg/ml inj., iron
and folic
acid t
ablets (l
arge) blue coloured (indigo c
armine) : e
ach sug
ar co
ated t
ablet sh
all cont
ain dried ferrous sulph
ate ip equiv
alent to element
al iron 60 mg
and folic
acid 0.5 mg ip, moxiflox
acin ointment 0.5%, lithium c
arbon
ate ip 450 mg t
ab, silver sulph
adi
azene 1% w/v cre
am, hydroxychloroquine t
ablet 400 mg ip, duloxetine t
ablet 10 mg ip, preg
ab
alin t
ablet 25 mg ip, c
arb
am
azepine* t
ablet 100 mg ip, cefixime or
al liquid 50 mg/5 ml ip, prednisolone or
al liquid 5 mg/5 ml usp, prednisolone or
al liquid 15 mg/5 ml usp, levodop
a (
a) + c
arbidop
a (b) t
ablet 100 mg (
a) + 25 mg (b) cr ip, dilti
azem injection 5 mg/ml ip, dobut
amine injection 50 mg/ml ip, esmolol injection 10 mg/ml ip, zinc oxide cre
am 10% ip, gum p
aint (t
annic
acid) usp, combo e
ar drops- chlor
amphenicol 5% w/v clotrim
azole 1% +lignoc
aine hydrochloride 2%, methylprednisolone t
ablet 4mg ip, vecuronium powder for injection 10 mg ip, hom
atropine eye drops 2% ip, imipr
amine t
ablet 75 mg ip, zolpidem t
ablet 10 mg, combin
ation of l
ab
a+ics formoterol 6mcg + flutic
asone 125 mcg, thi
amine t
ablet 100 mg ip,
aripipr
azole 5mg t
ab ip, clomiphene citr
ate 25mg t
ab ip, d
afl
az
acort 6mg t
ab, levos
albut
amol (1.25mg) + ipr
atropium (500mcg) respule, prochlorper
azine mesyl
ate (12.5mg) inj. ip, torsemide 10mg + spironol
actone 50 mg t
ab ip, bupropion 150mg t
ab, glucos
amine sulph
ate 1250 +chondroitin 1200 + di
acerein 100 t
ab, l
ansopr
azole 15mg t
ab, mefen
amic
acid 250 mg ip t
ab,
alpr
azol
am t
ablet 0.25 mg ip, nicotine p
atch 7 mg usp, nicotine p
atch 14 mg usp, nicotine p
atch 21 mg usp, (exclusive gst) gst will be ch
arged
as
applic
able, (exclusive gst) gst will be ch
arged
as
applic
able